141 related articles for article (PubMed ID: 37810655)
1. Lipidomics Profiling Reveals Serum Phospholipids Associated with Albuminuria in Early Type 2 Diabetic Kidney Disease.
Ye S; Hu YP; Zhou Q; Zhang H; Xia ZZ; Zhao SZ; Wang Z; Wang SY; Wang XY; Zhang YK; Chen ZD; Mao GY; Zheng C
ACS Omega; 2023 Oct; 8(39):36543-36552. PubMed ID: 37810655
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic Profiling of Amino Acids in Human Plasma Distinguishes Diabetic Kidney Disease From Type 2 Diabetes Mellitus.
Zhou C; Zhang Q; Lu L; Wang J; Liu D; Liu Z
Front Med (Lausanne); 2021; 8():765873. PubMed ID: 34912824
[No Abstract] [Full Text] [Related]
3. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling and correlations with clinical features reveal biomarkers indicative of diabetic retinopathy with diabetic kidney disease.
Fan X; Xu M; Chen X; Ren Q; Fan Y; Wang R; Chen J; Cui L; Wang Z; Sun X; Guo N
Front Endocrinol (Lausanne); 2022; 13():1001391. PubMed ID: 36277688
[TBL] [Abstract][Full Text] [Related]
5. Correlation of ACR and TcPO2 in diabetic kidney disease patients: A pilot study.
Sun J; Huang Y; Li L; Hu H; Liu Y; Zhang X; Zhang H; Pan B
J Diabetes; 2023 Jun; 15(6):488-495. PubMed ID: 37186455
[TBL] [Abstract][Full Text] [Related]
6. Assessment of urinary podocalyxin as an alternative marker for urinary albumin creatinine ratio in early stage of diabetic kidney disease in older patients.
Xie Y; Jin D; Qiu H; Lin L; Sun S; Li D; Sha F; Zhou W; Jia M
Nefrologia (Engl Ed); 2022; 42(6):664-670. PubMed ID: 36402681
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of UbA52 level in the urine of patients with type 2 diabetes mellitus and diabetic kidney disease.
Xu X; Dong Y; Liu M; Li Y; Zhang Y
Nefrologia (Engl Ed); 2021; 41(5):548-555. PubMed ID: 36165137
[TBL] [Abstract][Full Text] [Related]
8. HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson's Disease.
Zhi Y; Sun Y; Jiao Y; Pan C; Wu Z; Liu C; Su J; Zhou J; Shang D; Niu J; Hua R; Yin P
Front Pharmacol; 2021; 12():754185. PubMed ID: 34880754
[No Abstract] [Full Text] [Related]
9. Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease.
Ren X; Wang W; Cao H; Shao F
Front Endocrinol (Lausanne); 2023; 14():1180338. PubMed ID: 37305031
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.
Han YS; Chen JX; Li ZB; Chen J; Yi WJ; Huang H; Wei LL; Jiang TT; Li JC
Exp Biol Med (Maywood); 2021 Feb; 246(4):387-399. PubMed ID: 33175608
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of quantitative contrast-enhanced ultrasound (CEUS) for early detection of renal hyperperfusion in diabetic kidney disease.
Wang L; Wu J; Cheng JF; Liu XY; Ma F; Guo LH; Xu JM; Wu T; Mohan C; Peng A; Xu HX; Song YX
J Nephrol; 2015 Dec; 28(6):669-78. PubMed ID: 25712236
[TBL] [Abstract][Full Text] [Related]
12. Correlation Between Serum 25-Hydroxyvitamin D Levels in Albuminuria Progression of Diabetic Kidney Disease and Underlying Mechanisms By Bioinformatics Analysis.
Huang B; Wen W; Ye S
Front Endocrinol (Lausanne); 2022; 13():880930. PubMed ID: 35634488
[TBL] [Abstract][Full Text] [Related]
13. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
Zhang M; Zhao B; Xie J; Liang Y; Yang Z
Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
[TBL] [Abstract][Full Text] [Related]
14. 12(S)-hydroxyeicosatetraenoic acid is significantly increased in diabetic kidney disease and associated with renal function decline.
Xu J; Jin L; Sun Y; Zhang R; Chen X; Zhou R; Gu Y; Hu C
Diabetes Metab Res Rev; 2022 Sep; 38(6):e3554. PubMed ID: 35667014
[TBL] [Abstract][Full Text] [Related]
15. Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?
Laranjinha I; Matias P; Mateus S; Aguiar F; Pereira P; Perneta Santos M; Costa R; Lourenço A; Guia J; Barata JD; Campos L
Nefrologia; 2016; 36(5):503-509. PubMed ID: 27445098
[TBL] [Abstract][Full Text] [Related]
16. [Therapy for CKD and DKD].
Abe T
Nihon Yakurigaku Zasshi; 2023; 158(4):319-325. PubMed ID: 37394553
[TBL] [Abstract][Full Text] [Related]
17. A lipid metabolite lipidomics assay for prediction and severity evaluation of rotator cuff injury.
Huang H; Jiesisibieke D; Zhou X; Zhang Z; Duan X; Cheng X; Shao Z; Wang J; Zhang X
Front Nutr; 2022; 9():1000947. PubMed ID: 36211515
[TBL] [Abstract][Full Text] [Related]
18. Lipid profiling in malignant mesothelioma reveals promising signatures for diagnosis and prognosis: A plasma-based LC-MS lipidomics study.
Chen Z; Song S; Yang C; Dai Z; Gao Y; Li N; Zhu J; Mao W; Liu J
Clin Chim Acta; 2022 Jan; 524():34-42. PubMed ID: 34843704
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum trimethylamine oxide levels as potential biomarker for diabetic kidney disease.
Huang Y; Zhu Z; Huang Z; Zhou J
Endocr Connect; 2023 Jul; 12(8):. PubMed ID: 37183928
[TBL] [Abstract][Full Text] [Related]
20. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
